Organovo Holdings, currently known through the stock ticker (ONVO, Financial), will undergo a rebranding initiative, transitioning to VivoSim Labs, Inc. This change reflects the company's ongoing commitment to advancing its 3D bioprinting and legacy technology expertise.
Effective April 24, 2025, the company will adopt the new name, VivoSim Labs, Inc., and commence trading on the Nasdaq Capital Market under the new ticker symbol "VIVS." This rebranding will not necessitate any immediate actions by existing stockholders, as the company's common stock continues its unchanged listing on the Nasdaq Capital Market. Furthermore, the CUSIP number assigned to the company's common stock will remain the same.
